NCT03881943View on ClinicalTrials.gov

Ticagrelor Monotherapy Compared to Aspirin Monotherapy in Patients With History of ACS

PHASE4CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

January 31, 2017

Primary Completion Date

December 21, 2018

Study Completion Date

December 21, 2018

Conditions
Acute Coronary Syndrome
Interventions
DRUG

Ticagrelor 60 mg

Potent antiplatelet agent, 60mg twice daily for 3 months

DRUG

Aspirin 100 MG Oral Tablet, Enteric Coated

antiplatelet agent, 100mg once daily for 3 months

Trial Locations (1)

Unknown

Prof. HF Tse, Hong Kong

All Listed Sponsors
lead

The University of Hong Kong

OTHER

NCT03881943 - Ticagrelor Monotherapy Compared to Aspirin Monotherapy in Patients With History of ACS | Biotech Hunter | Biotech Hunter